Featured

Long-COVID devastating lives according to WHO

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 / chris

Long COVID is “devastating” the lives and livelihoods of tens of millions of people, and wreaking havoc on health systems and economies, WHO director general, Dr Tedros Adhanom Ghebreyesus has warned as he urged countries to launch “immediate” and “sustained” efforts to tackle the “very serious” crisis. www.theguardian.com/society/2022/oct/12/long-covid-who-tedros-adhanom-ghebreyesus? The world has never been in a […]

Long-COVID devastating lives according to WHO Read More »

Origins of COVID-19 once again spark debate

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 / chris

The acrimonious debate over the origins of the COVID-19 pandemic flared up again last week with a report from an expert panel concluding that SARS-CoV-2 likely spread naturally in a zoonotic jump from an animal to humans—without help from a lab. www.science.org/content/article/evidence-suggests-pandemic-came-nature-not-lab-panel-says “Our paper recognizes that there are different possible origins, but the evidence towards

Origins of COVID-19 once again spark debate Read More »

COVID-19 cases rise across Europe

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter / chris

Another wave of COVID-19 infections may have begun in Europe as cases begin to tick up across the region, the World Health Organization (WHO) and European Centre for Disease Prevention and Control (ECDC) said last Wednesday. www.medscape.com/viewarticle/982296?src=wnl_edit_tpal&uac=398271FG&impID=4751294&faf=1 “Although we are not where we were one year ago, it is clear that the COVID-19 pandemic is

COVID-19 cases rise across Europe Read More »

US extends COVID-19 pandemic status

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 / chris

The Biden administration extended the Covid-19 pandemic’s status as a public health emergency for another 90 days, preserving measures such as expanded Medicaid and higher payments to hospitals. The decision follows comments President Joe Biden made in September describing the pandemic as over. Some Republican lawmakers said afterward that the administration should wind down its

US extends COVID-19 pandemic status Read More »

Why Are Some Global Health Efforts Failing? | Opinion

Leave a Comment / covid, Featured, infectious diseases / chris

The COVID-19 pandemic has highlighted the considerable inequality found in health systems across the globe. While medical advances are saving countless lives, many tragic deaths have occurred across the world from COVID-19, as well as countless other diseases, simply because people are unable to access these lifesaving treatments. In situations like the pandemic, any country

Why Are Some Global Health Efforts Failing? | Opinion Read More »

Indonesia launches domestic COVID-19 vaccination

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 / chris

Indonesia launched its first home-grown COVID-19 shot Thursday to help reduce the world’s fourth most populous nation’s dependency on imported vaccines. www.medscape.com/viewarticle/982435?src=wnl_edit_tpal&uac=398271FG&impID=4751294&faf=1 President Joko Widodo announced the vaccine brand, IndoVac, as a new milestone for Indonesia’s pharmaceutical industry that will manufacture primary series vaccines, booster vaccines and vaccines for children, which have been in development

Indonesia launches domestic COVID-19 vaccination Read More »

Omicron subvariants becoming dominant strains

Leave a Comment / covid, Featured, infectious diseases, News, Newsletter, sars-cov-2 / chris

The subvariants known as BQ.1.1, BQ.1, BQ.1.3, BA.2.3.20 and XBB are among the fastest spreading of the main Omicron lineages. Based on UK data, the BQ variants, as well as BA.2.75.2 and BF.7 are the most concerning due to their growth advantage and immune evasiveness, the US health security agency has said. BF.7 has also

Omicron subvariants becoming dominant strains Read More »

Maiden Pharma’s license suspended following cough syrup deaths

Leave a Comment / Featured, News, West Africa / chris

Indian authorities have suspended the licence of Delhi-based drugmaker, Maiden Pharma, after it failed to furnish information on cough syrup related deaths in West Africa’s The Gambia.The company is accused of supplying cough syrup that led to the deaths of 66 children in The Gambia.Meanwhile, police in The Gambia are investigating the deaths of 66

Maiden Pharma’s license suspended following cough syrup deaths Read More »

A new monoclonal antibody treatment for Alzheimer’s disease

Leave a Comment / Featured, News, Non Communicable Diseases / chris

The pharmaceutical companies Biogen and Eisai last week announced that a monoclonal antibody treatment reduced cognitive decline by 27% in people with early stage Alzheimer’s compared with those on a placebo after 18 months. www.science.org/content/article/news-glance-ai-regulation-renewable-energy-and-alzheimer-s-therapy? Lecanemab belongs to a class of therapies that break down or inhibit build up of amyloid plaques in the brain,

A new monoclonal antibody treatment for Alzheimer’s disease Read More »

COVID increasing once more in the UK

Leave a Comment / covid, Featured, infectious diseases, News, sars-cov-2 / chris

According to data from the Office for National Statistics (ONS), about one in 65 people in England – an estimated 857,400 individuals – had COVID in the week ending 17 September, up from 766,500 people, or one in 70, the week before. www.theguardian.com/global/2022/oct/06/rising-uk-covid-levels-whats-driving-it-and-what-will-happen-next? An increase was also seen in Wales, while in Northern Ireland and

COVID increasing once more in the UK Read More »

Pandemic Latest News

Why Are Some Global Health Efforts Failing? | Opinion

Maiden Pharma’s license suspended following cough syrup deaths

A new monoclonal antibody treatment for Alzheimer’s disease

COVID increasing once more in the UK

About Us

Newsletter